News
Experts say the tariffs are unlikely to bring back production of generic medicines, given their slim profit margins ...
Shares of pharma companies were hit on Friday after the industry’s joy over not figuring in the U.S. reciprocal tariff list proved short-lived with President Donald Trump announcing such a levy is ...
Sensex jumped 1007.23 pts or 1.31 per cent to 78,051.52 as at 12.33 pm, and Nifty 50 soared 267.05 pts or 1.14% to 23,704.25.
The S&P 500 rose 9.5 percent after President Trump announced he would pause his “reciprocal” tariffs for 90 days, but ...
Withdrawing data from the company's website does not fully protect information since 23andMe's business ... pharmaceutical ...
Explore how recent tariffs, market turmoil, and economic indicators like rising debt and job losses are shaping a potential stagflation scenario.
Donald Trump slapped a 10 per cent tariff on US imports of UK goods - and experts believe a wave of price rises will hit American consumers first, with Brits later facing similar increases.
The Investor introduces the content of the Vietnam section (pages 370-377) in the 2025 National Trade Estimate Report on ...
U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...
President Donald Trump's administration is ramping up probes into U.S. semiconductor and pharmaceutical imports ... Get a brief on the top business stories of the week, plus CEO interviews ...
Indian pharmaceutical stocks experienced a downturn following Donald Trump's renewed threat to impose tariffs on pharmaceutical imports. The Nifty Pharma index fell by 1.7%, with major companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results